Institution Profile
Montreal Neurological Institute-Hospital
Contact Information
Research Center Contact
Facilities
Institut-Hôpital neurologique de Montréal
-
3801 Rue University, H3A2B4, Montréal
-
Served Clientele / Population
Therapeutic Areas
Types of Research Projects
Research Ethics Board
Frequency
Mensuelle
Laboratories
Optilab Laboratory certified ISO 15189
Laboratory of the Clinical Research Unit at the Neuro; central laboratories chosen by the study sponsor
Platforms and Technical Facilities
Research Pharmacy
Schedule
Receiving unblinded monitoring visits
Equipment
Level 3 Containment Laboratory
Schedule
Laboratory accreditations
Clinical Laboratory Improvement Amendments (CLIA),College of American Pathologist (CAP),ISO15189
Equipment
Phase 1 Unit or Capacity
Overnight accommodation
Yes
Beds available for overnight stays
1 to 3
Outpatient care reception
Yes
Number of chairs available for outpatient care
6
Care services for the pediatric population
No
Infusion Center or Chair
Description
Infusion center dedicated exclusively to clinical research
Negative pressure rooms
Number
1
Imaging
Equipment
Pharmacology Platform
Reserved for research only
Technical Platform in Neurophysiology (EEG / EMG)
Reserved for research only
Schedule
Equipment
Operating Room
Reserved for research only
Sleep Laboratory
Reserved for research only
Schedule
Biobank Service
Name
Neuro Open Biobank
Description
The Neuro C-BIG Repository is an open science resource created to promote research and scientific discoveries in the field of neurological diseases and to accelerate the development of new treatments for the benefit of patients worldwide. Its ever-growing collection of biological samples, longitudinal clinical and neuropsychiatric information, imaging, and genetic data from patients with neurological diseases and healthy control subjects is made publicly available to support translational research globally, in accordance with the principles of open science.
Other Platforms
- We are developing a platform dedicated to gene and cell therapies. We are actively seeking partnerships in this field.